GN0M.DE vs. XMLH.DE
GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) and XMLH.DE (L&G Healthcare Technology & Innovation UCITS ETF USD Acc) are both Health & Biotech Equities funds - GN0M.DE tracks the Solactive Genomics while XMLH.DE tracks the ROBO Global Healthcare Technology and Innovation Index. Both are passively managed. Over the past 3 years, GN0M.DE returned 3.54%/yr vs 7.34%/yr for XMLH.DE. Their correlation of 0.83 suggests significant overlap in exposure. GN0M.DE charges 0.50%/yr vs 0.49%/yr for XMLH.DE.
Performance
GN0M.DE vs. XMLH.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GN0M.DE achieves a 24.01% return, which is significantly higher than XMLH.DE's 8.59% return.
GN0M.DE
- 1D
- 0.00%
- 1M
- 7.73%
- 6M
- 16.33%
- YTD
- 24.01%
- 1Y
- 61.68%
- 3Y*
- 3.54%
- 5Y*
- —
- 10Y*
- —
XMLH.DE
- 1D
- -1.84%
- 1M
- 8.59%
- 6M
- 2.66%
- YTD
- 8.59%
- 1Y
- 38.31%
- 3Y*
- 7.34%
- 5Y*
- -2.64%
- 10Y*
- —
GN0M.DE vs. XMLH.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 24.01% | 5.67% | -12.40% | -9.04% | -32.50% | -7.53% |
XMLH.DE L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 8.59% | 11.69% | 8.01% | -4.50% | -29.19% | -5.48% |
Correlation
The correlation between GN0M.DE and XMLH.DE is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.77 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.79 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2021 | 0.83 |
The correlation between GN0M.DE and XMLH.DE has been stable across timeframes, ranging from 0.77 to 0.83 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GN0M.DE vs. XMLH.DE — Risk / Return Rank
GN0M.DE
XMLH.DE
GN0M.DE vs. XMLH.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GN0M.DE | XMLH.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.37 | ||
| Sortino ratioReturn per unit of downside risk | +0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.31 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 3.72 | 2.47 | +1.25 |
| Martin ratioReturn relative to average drawdown | 9.36 | 5.53 | +3.83 |
Loading charts...
Drawdowns
GN0M.DE vs. XMLH.DE - Drawdown Comparison
The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than XMLH.DE's maximum drawdown of -51.48%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and XMLH.DE.
Loading charts...
Drawdown Indicators
| GN0M.DE | XMLH.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.19% | -51.48% | -15.71% |
Max Drawdown (1Y)Largest decline over 1 year | -16.68% | -15.46% | -1.22% |
Max Drawdown (3Y)Largest decline over 3 years | -45.68% | -28.40% | -17.28% |
Max Drawdown (5Y)Largest decline over 5 years | — | -50.58% | — |
Current DrawdownCurrent decline from peak | -35.28% | -21.11% | -14.17% |
Average DrawdownAverage peak-to-trough decline | -42.93% | -25.17% | -17.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.61% | 6.91% | -0.30% |
Volatility
GN0M.DE vs. XMLH.DE - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 7.89% compared to L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) at 7.32%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than XMLH.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GN0M.DE | XMLH.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.89% | 7.32% | +0.57% |
Volatility (6M)Calculated over the trailing 6-month period | 20.28% | 15.92% | +4.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.38% | 21.00% | +7.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.39% | 22.54% | +8.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.39% | 23.80% | +7.59% |
GN0M.DE vs. XMLH.DE - Expense Ratio Comparison
GN0M.DE has a 0.50% expense ratio, which is higher than XMLH.DE's 0.49% expense ratio.
Dividends
GN0M.DE vs. XMLH.DE - Dividend Comparison
Neither GN0M.DE nor XMLH.DE has paid dividends to shareholders.
Frequently Asked Questions
GN0M.DE and XMLH.DE have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XMLH.DE is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XMLH.DE is cheaper with a 0.49% expense ratio, compared with 0.50% for GN0M.DE.
GN0M.DE tracks Solactive Genomics, while XMLH.DE tracks ROBO Global Healthcare Technology and Innovation Index. They also come from different issuers: Global X and L&G. Their fees differ too: 0.50% for GN0M.DE and 0.49% for XMLH.DE.
Find the right allocation for GN0M.DE and XMLH.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer